4//SEC Filing
Novus Therapeutics, Inc. 4
Accession 0000899243-17-017764
$ELDNCIK 0001404281operating
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:07 PM ET
Size
9.7 KB
Accession
0000899243-17-017764
Insider Transaction Report
Form 4
McBride John S.
Director
Transactions
- Award
Stock Option (Right to Buy)
2017-06-30+18,000→ 18,000 totalExercise: $5.85Exp: 2027-06-30→ Common Stock (18,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock. The shares will vest ratably each quarter over three years beginning on June 30, 2017.
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001404281
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:07 PM ET
- Size
- 9.7 KB